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Abstract: Aromatic plants have a long and significant history in the traditional medicine of many
countries. Nowadays, there is an increasing interest in investigating the biological properties of
aromatic plant extracts mainly due to their diversity, high availability, and low toxicity. Greece
is abundant in aromatic plants, which can be attributed to the country’s geographical position,
the morphology of its landscape, and its numerous mountainous and insular areas. In the past 15 years,
a number of aromatic plant extracts of Greek origin have been studied for their bioactivities, including
their antiproliferative potential against different types of cancer. Although the pharmacological
activities of specific species of Greek origin have been reviewed before, no gathered information on
explicitly Greek species exist. In this review, we summarize existing data on the antiproliferative
activity of extracts isolated from Greek aromatic plants and discuss their molecular mode(s) of
action, where available, in order to identify promising extracts for future research and link chemical
constituents responsible for their activity. We conclude that essentials oils are the most frequently
studied plant extracts exhibiting high diversity in their composition and anticancer potential, but also
other extracts appear to be worthy of further investigation for cancer chemoprevention.
Keywords: aromatic plants; natural extracts; Greece; antiproliferative activity; cancer
1. Introduction
Aromatic plants take their name from the distinct aroma they produce, which is attributed to
a mixture of volatile compounds extracted as essential oils. They constitute 10% of the plant kingdom
(17,000 species) and are distributed all over the world, mostly in temperate and warm countries [1].
Greece is abundant in aromatic plants. Its geographical position, the morphology of its landscape,
and the numerous mountainous and insular areas (109 out of 225 habitat types encountered in the
European Union are found in Greece) [2] contribute to the country’s high plant diversity and endemism
(6600 species and subspecies) [3], explaining its long-documented ethnopharmacological history.
Most of the plants collected for research purposes in the Greek area have been obtained from Central
Greece and Crete and belong to the Lamiaceae family [4]. In recent years, increased interest has been
focused on studying the biological properties of aromatic plant extracts mostly due to their high
availability and few side-effects. Among their reported properties is their ability to affect proliferation
of cancer cells and induce apoptosis, one of the most important features of cancer chemoprevention.
In Greece, cancer is the second leading cause of death after cardiovascular diseases.
With a population of approximately 11,000,000, there was an expected number of 67,400 new cancer
cases and 33,200 deaths in 2018 (~6% and 3% of the population, respectively) [5]. Although overall
cancer rates have not increased since 2014 (~29,000 deaths), there has been an increase in the number
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of specific cancer types including lung cancer in men, colorectal, breast, pancreatic, and prostate
cancer [6]. According to the International Agency for Research on Cancer (IARC) and the World Cancer
Observatory, Greece was in the 28th place in cancer rates globally for men and women in 2018 with
lung cancer having the highest rates in incidence and mortality for both sexes (one of the highest rates
for men in Europe) followed by breast and colorectal cancer [5,7]. Unfortunately, there are no data
available on the correlation between the anticancer activity of aromatic plants and tumor incidence
in Greece. It is challenging, though, to investigate how isolated food components may contribute to
cancer incidence and/or affect mortality rates as assessing diet through dietary patterns has become
popular in diet–disease investigations [8]. However, cancer reports suggest that foods rich in vitamins
and phytochemicals can act as chemopreventive agents reducing the risk of various types of cancer,
especially colorectal cancer [9,10]. In addition, there are studies with Greek participants that show
that the adoption of the Mediterranean diet (characterized by high intake of fruit, vegetables, nuts,
whole grains, and olive oil; a moderate intake of fish and dairy products; and low intake of meat,
especially red meat), reduce cancer-related and total mortality [11,12].
Currently, literature is lacking thorough research on the anticancer activity of aromatic extracts
of Greek origin, which would be very useful for the appraisal and comparison of the data in this
increasingly growing field. Therefore, the present review summarizes all the existing data on various
plant extracts discussing their molecular mode(s) of action where available.
2. Methods
We performed a systematic search on Pubmed, Google scholar, and Scopus databases using the
keywords “aromatic plants”, “plant extracts”, “cancer”, “antiproliferative”, “anticancer”, “Greece”,
“Greek”. We focused our research on selected studies dealing only with the activity of aromatic plant
extracts and not plants in general or isolated compounds against cancer in vitro and/or in vivo. We also
excluded any study were the plant material was not harvested from the Greek area.
3. Results
Our research was restricted only to aromatic plant extracts and not plants in general or isolated
compounds. We found 28 research studies conducted from 1996 to July 2019, dealing mostly with
essential oils and methanolic extracts. In these studies, 48 species were investigated for their properties,
the majority of which belong to the Lamiaceae family, in accordance with previous published data [4]
(Figure 1a). Only four studies included in vivo models; three of them were investigating Pistacia
lentiscus var. Chia extracts and one the essential oil of Origanum Onites L. (Figure 1b). In the majority of
these studies, human cancer cells were used to evaluate cytotoxicity, with colon cancer cells being the
most frequently used, followed by hepatocellular and breast carcinomas. Finally, only four studies
included testing the cytotoxicity on normal cells, too (PBMCs, African green monkey kidney, rabbit
skin, mouse adipose areolar, and HaCat cells). The available data are summarized in Table 1.
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 Figure 1. (a) The percentage of plant families of the species studied for their antiproliferative activity.
(b) The percentage of studies on aromatic plant extracts performed in (i) in vitro models, (ii) in vitro
and in vivo models, or (iii) only in in vivo models.
Pistacia lentiscus var. Chia, commonly known as Chios mastic, is the plant mostly studied (nine
studies) and is the only one with available and more detailed information on its molecular mode(s)
of action on various cancer models. Pistacia lentiscus var. Chia is a variety endemic to Chios island,
with high economic value as it is the only variety that produces resin when its bark is scored. When the
essential oil of the resin was incubated with breast, colon, and ovarian adenocarcinoma cell lines
(MCF-7, LoVo, 2008) for 3 h, followed by a 21 h recovery period, it demonstrated the weakest
activity compared to other Pistacia species originating from other countries (EC50 > 500 µg/mL) [13].
The essential oil has been also studied against human leukemic and melanoma cells and mouse
lung carcinoma (K562, Lewis lung carcinoma cells, B16, respectively) and also in vivo in a lung
cancer mouse model. These studies revealed that mastic oil reduces cell viability and tumor growth.
In addition, it was shown that it induces apoptosis in cancer cells, reduces the expression of chemokines,
limits their invasive and adhesive potential, and is an inhibitor of angiogenesis via the reduction of
VEGF expression and neovascularisation [14–17]. When the oil was tested against colon carcinoma,
it showed significant dose- and time-dependent cytotoxicity in vitro and tumor reducing capacity
in vivo, which was higher than the activity of its major components, α-pinene and myrcene, tested
either alone or in combination in the ratio found in the oil mixture. Furthermore, downregulation in
the levels of the proliferation markers Ki-67 and survivin and attenuation of cancer cell migration was
observed [18]. A hexane and an ethanol extract of mastic have been also studied for their anticancer
potential in vitro against a human colon cancer cell line (HCT116) and in vivo in an experimental colon
cancer mouse model. Both extracts caused dose-dependent inhibition of cell growth, while the hexane
extract also caused tumor growth suppression. Furthermore, the extracts caused G1 cell cycle arrest,
induction of apoptosis via the activation of caspases 3, 8 and 9, while it was found that the cell death
caused by the ethanol extract is independent of p53, Bcl-2, and FADD [19–21].
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Table 1. Summary of the antiproliferative activity of extracts isolated from Greek aromatic plants. The cell lines are human unless otherwise stated. N.d. = not
determined. (−) in major component and collection location columns indicates that the authors report no data on the major components and collection location,
respectively. (–) in dose/concentration column indicates that the concentrations used were not reported.
Family Species Extract MajorComponents
Collection














Caco2 EC50 48 h = 0.0368 ± 0.0225 mg/mL
EC50 72 h = 0.0176 ± 0.0035 mg/mL
HT-29 EC50 48 h = 0.1751 ± 0.0028 mg/mL
EC50 72 h = 0.0762 ± 0.0057 mg/mL
CT26 EC50 48 h = 0.1335 ± 0.054 mg/mL
EC50 72 h = 0.0104 ± 0.0004 mg/mL [18]
Colon cancer mouse model
(in vivo) 0.58 g/kg b.w.
44–52% tumor volume inhibition
Cancer cell migration attenuation
Downregulation in the expression levels
of Ki-67 and survivin




– EC50 > 500 µg/mL [13]





K562: Reduction of viability. Induction of
apoptosis; Reduction of VEGF release
levels; Inhibition of endothelial cells
proliferation and neovascularization;
Erk1/2 reduction
B16: Reduction of VEGF release levels
[14]
Essential oil α-Pinene (~70%) Commercial
Mouse Lewis lung carcinoma 0.01–0.02% v/v
Cell proliferation suppression; VEGF
release reduction; Chemokine release
reduction; GTPases Ras, RhoA and
NF-κB-dependent reporter gene
expression decrease [16]
Lung cancer mouse model
(in vivo) 45 mg/Kg b.w.
Tumor growth suppression; Apoptosis
induction; Neovascularization reduction;
Chemokine expression reduction GTPases,
Ras, RhoA and NF-κB-dependent reporter
gene expression decrease
Essential oil − − Mouse Lewis lung carcinoma 0.01% v/v
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Essential oil − Commercial Mouse Lewis lung carcinoma 0.01–0.04% v/v
Reduction of MMP-2, ICAM-1 and
VCAM-1 expression levels; attenuation of
f-actin fiber formation; limitation of cell





hexane extract Caryophyllene − Colon carcinoma HCT116 25–100 µg/mL
Dose-dependent growth inhibition
G1 cell cycle arrest
Induction of apoptosis




hexane extract − −
Colon cancer mouse model
(in vivo) 200 mg/Kg b.w. Tumor growth suppression [21]
Mastic gum
ethanol extract − − Colon carcinoma HCT116 0.2–0.6% v/v
Dose-dependent inhibition of cell growth
G1 cell cycle arrest
cell death is independent of p53, Bcl-2 and
FADD
Induction of apoptosis
Activation of caspases 3, 8, 9
PARP degradation
[19]










Rat glioma C6 0.5–10 mg/mL
EC50 = 3 mg/mL
No apoptosis induction
Colony formation impairment
Calpain-dependent cell death, possibly
autophagy
Synergistic effect with temozolomide at
certain combinations
[22]













HepG2 EC50 = 74 ± 2.8 µg/mL
MCF-7 EC50 = 89 ± 1.4 µg/mL
Caco2 EC50 = 71 ± 2.6 µg/mL
THP-1 EC50 = 111 ± 3.6 µg/mL
A375 EC50 = 9.1 ± 0.6 µg/mL
[23]
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HepG2: EC50 = 0.091 ± 0.012 mg/mL
MCF-7: EC50 = 0.16 ± 0.012 mg/mL
Caco2:EC50 = 0.013 ± 0.00001 mg/mL
A375:EC50 = 0.0057 ± 0.0019 mg/mL
HaCat:EC50 = 0.024 ± 0.0014 mg/mL
[24]
Fortunella







HepG2 EC50 = n.d.
MCF-7 EC50 = n.d.
Caco2 EC50 = 0.1 ± 0.027 mg/mL
THP-1 EC50 = 0.1 ± 0.0023 mg/mL
[25]





HepG2 EC50 = 0.39 ± 0.0282 mg/mL
MCF-7 EC50 = 0.3 ± 0.01 mg/mL
Caco2 EC50 = 0.25 ± 0.04 mg/mL
THP-1 EC50 =0.11 ± 0.0001 mg/mL
Lamiaceae
Mentha spicata Essential oil Carvone (85.41%) − 0.00067–0.96mg/mL
HepG2 EC50 = 0.22 ± 0.038 mg/mL
MCF-7 EC50 = 0.284 ± 0.02 mg/mL
Caco2 EC50 = 0.162 ± 0.0035 mg/mL








HepG2 EC50 = 0.18 ± 0.028 mg/mL
MCF-7 EC50 = 0.17 ± 0.022 mg/mL
Caco2 EC50 = 0.071 ± 0.003 mg/mL









HeLa: EC50 = 164.61 ± 2.58 µg/mL
FemX: EC50 = 191.36 ± 2.42 µg/mL
K562: EC50 = 157.03 ± 2.25 µg/mL
SKOV3: EC50 >200 µg/mL [26]
























MCF-7: EC50 = 417.53 ± 53.4 µg/mL
HeLa: EC50 = 218.07 ± 64.1 µg/mL
HCT116:EC50 = 474.07 ± 23.14 µg/mL
FM3: EC50 = 453.15 ± 37.91 µg/mL
62.20% growth inhibition of PBMCs at
300 µg/mL
[27]
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Complete cell death in all cell lines at
0.0001% v/v
Reduction of Vero viability at 0.00002% v/v















HT-29: 58.00 ± 0.70 µg/mL
CT26: 71.70 ± 1.20 µg/mL
EC50 72 h
A375: 8.90 ± 0.70 µg/mL
MCF-7: 10.00 ± 1.70 µg/mL
HepG2: 23.00 ± 4.20 µg/mL HT-29:
0.35 ± 0.20 µg/mL CT26: 1.10 ± 0.30
µg/mL




Colon cancer mouse model





Essential oil Carvacrol (52.18%)
γ-terpinene (8.4%) Crete
Hepatocellular carcinoma
HepG2 0.00007–0.1% v/v EC50 = 0.0069 ± 0.00014% v/v [31]






LoVo: EC50 24 h = 84.76 ± 1.03 µg/mL
EC50 48 h = 72.26 ± 1.05 µg/mL
HepG2: Reduction of cell viability
[32]
Dichloro-
methane residue Ursolic acid
Crete
Mouse leukemia P-388
Non-small cell lung carcinoma
NSCLC-N6
–
P-388: EC50 = 8 µg/mL
NSCLC-N6: EC50 = 14 µg/mL [33]
Ethanolic
extract − Almost inactive
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Crete Colon carcinoma HT-29
Prostate adenocarcinoma PC-3
0.2, 0.6, 1 µg/µL
PC3 antiproliferative activity: Origanum
dictamnus >marjoram>sage> rosemary>St
John’s wort>thyme
HT-29 antiproliferative activity: Origanum
dictamnus >rosemary>
thyme>sage>marjoram>St John’s wort
IL-8 decrease in HT-29: sage> Origanum
dictamnus >thyme> marjoram>St John’ s
wort> rosemary
IL-8 decrease in PC-3: Thyme>sage >
Origanum dictamnus >marjoram >
rosemary> St John’s wort
Reduced levels of the p65 NF-kB subunit
by St John’s Wort in HT29













































38/15 & 41/15: Did not affect cell viability
43/15: Reduced viability to 82.04% only at




NAT: Reduced viability to 41.14% only at
the highest concentration




Urinary bladder carcinoma T24








T24:AS EC50 = 4.7 µL/mL
MS EC50 = 1.1 µL/mL
ME EC50 = 18 µg/mL
PEE EC50 = 5 µg/mL
NBT-II: ME EC50 = 13 µg/mL
PEE EC50 = 7 µg/mL
Indication of apoptosis induction in T24





extract (ME) Hyperforin (7.62%)
Petroleum ether
extract (PEE) Hyperforin (18.9%)
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Family Species Extract MajorComponents
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EC50 of all extracts against all cell cancer
lines > 100 mg/mL, apart from:
H. empetrifolium Wild Parnitha:
Caco2 EC50 = 51.3 mg/mL
HepG2 EC50 = 43.7 mg/mL
H. empetrifolium Wild Hymettus:
Caco2 EC50 = 54.2 mg/mL
HepG2 EC50 = 45.8 mg/mL
H. empetrifolium Wild Parnon:
Caco2 EC50 = 29 mg/mL







































COR-L23: EC50 = 80.7 ± 2.1µg/mL
Caco2: EC50 = 164 ± 2.1 µg/mL
C32: EC50 >200 µg/mL
[38]









COR-L23: EC50 = 104 ± 2.1 µg/mL
Caco2: EC50 >200 µg/mL










COR-L23: EC50 = 143 ± 2.1 µg/mL
Caco2: EC50 = 92.2 ± 2.1 µg/mL
C32: EC50 = 135 ± 2.1 µg/mL
Teucrium polium






COR-L23: EC50 = 104 ± 2.1 µg/mL
Caco2: EC50 = 52.7 ± 2.1 µg/mL
C32: EC50 = 91.2 ± 2.1 µg/mL
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0.2, 0.6, 1 µg/µL
HT-29: Pink savory most effective,
chamomile least cytotoxic
PC-3: Pink savory most effective,
chamomile and mountain tea least
cytotoxic
IL-8 decrease in HT-29: mountain tea >
pennyroyal > chamomile > Origanum
microphyllum > pink savory> Origanum
vulgare
IL-8 decrease in PC-3: Origanum
microphyllum > pennyroyal > pink savory
> Origanum vulgare > chamomile >
mountain tea
Reduction of p65 NF-kB subunit only by



























Normal mouse adipose areolar
cells
10–100 µg/mL
EC50 of all extracts against all cell
cancer lines > 75 µg/mL, apart from:
Clinopodium vulgare:
MCF-7 EC50 = 60.4 µg/mL
Rosmarinus officinalis:
MCF-7 EC50 = 42.6 µg/mL
Thymus parnassicus Halácsy:
Caco2 EC50 = 44.6 µg/mL
HepG2 EC50 = 50.3 µg/mL
MCF-7 EC50 = 54.7 µg/mL
Rosmarinus officinalis was the most
cytotoxic against a normal mouse adipose


















officinalis L. - Zante Island
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Normal mouse adipose areolar
cells
10–100 µg/mL
EC50 of all extracts against all cell
cancer lines > 75 µg/mL, apart from:
Clinopodium vulgare:
MCF-7 EC50 = 60.4 µg/mL
Rosmarinus officinalis:
MCF-7 EC50 = 42.6 µg/mL
Thymus parnassicus Halácsy:
Caco2 EC50 = 44.6 µg/mL
HepG2 EC50 = 50.3 µg/mL
MCF-7 EC50 = 54.7 µg/mL
Rosmarinus officinalis was the most
cytotoxic against a normal mouse adipose
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Citrus medica (citron) is an evergreen shrub or small tree that produces citron, probably the only
citrus fruit known in Europe in ancient times that has been extensively used for its medicinal properties
as reviewed in detail in [41]. It was found that the oil of citron is cytotoxic against human cancer cell
lines in vitro, especially against the colon carcinoma Caco2, while it affected a non-tumorigenic human
cell line to a lesser extent. Its cytotoxicity was higher compared to its major component, limonene [24].
Lippia citriodora (or Aloysia citriodora, Aloysia triphylla), commonly known as lemon verbena,
belongs to the Verbenaceae family. It was cultivated in South and Central America and was brought
to Europe in the 17th century [42]. Its leaves are mainly used for the preparation of infusions and
decoctions, usually consumed for the relief of gastroinstestinal problems, but they have also been used
as anti-spasmodic, diuretic, or sedatives [43]. There are published data on the antiproliferative activity
of the essential oil from plants of different origin (Morocco and Colombia), but only one study on the
bioactivities of the Greek oil exists. Lemon verbena oil demonstrated high antiproliferative activity
against a panel of human cancer cell lines (A375 > Caco2 > HepG2 > MCF-7 > THP-1), which was
lower than its major component, citral, possibly due to the lower DNA-damaging effect it was shown
to possess [23].
Satureja parnassica spp. parnassica is an aromatic plant endemic to Central and Southern Greece.
Although literature is sparse regarding its activity, existing studies reveal a potent antimicrobial and
insecticidal profile of its essential oil [44,45]. Satureja thymbra (common names: Thyme-leaved savory,
pink savory, thrubi) is an aromatic plant endemic to the Mediterranean region and is the most common
specimen of the Satureja genus. It is regarded as oil-rich and its essential oil has been tested against
several models and was shown to possess potent antioxidant, antifungal, antibacterial, antiviral, and
insecticidal properties [44–49]. In a study published in 2016, the antiproliferative activity of the essential
oils of S. thymbra and S. parnassica collected after their flowering season (August and September,
respectively) and their major components were investigated [28]. It was shown that the oil of S. thymbra
was more cytotoxic against MCF- 7 cells, possibly due to its higher content in carvacrol, a phenol with
significant bioactivities [50].
Origanum vulgare spp. hirtum (also known as Greek oregano) is considered the best for culinary
purposes. It is the most common O. vulgare subspecies in the Greek area and has shown great variation
in its chemical composition depending on the cultivation area [51]. Its essential oil was studied against
two normal cell lines of monkey and rabbit origin (Vero, RSC, respectively) and two human cancer cell
lines (Hep-2, HeLa) without exhibiting any cancer-specific cytototoxicity. In fact, the oil was found to
be more cytotoxic against Vero cells compared to the other cell lines [29].
Another member of the Origanum genus, Origanum Onites L., is commercially known as Turkish
oregano and can be mainly found in Turkey, but also in Greece and a small part of Sicily. Different extracts
of the plant are used for the relief of common health problems and this has led to the investigation
of their pharmacological properties, as well (reviewed in [52]). In a recent study, the essential oil of
O. Onites isolated from plants collected in Northern Greece has shown dose-dependent antiproliferative
activity in vitro, especially against the colon cancer cell line HT-29 (followed by A375, MCF-7 and
HepG2 carcinomas). Treatment with the oil caused time-dependent cytotoxicity against HT-29 and
CT26 cells (murine colon cancer cell line), attenuation of their migration, and apoptosis-like features,
while oral administration for 13 days significantly inhibited the growth of CT26 tumors in mice [30].
Origanum dictamnus (dittany of Crete), is a perennial plant endemic to the island of Crete that grows
at different altitudes. The essential oil of the plant demonstrated time-dependent cytotoxicity against
the LoVo colon cancer cell line, while it reduced the viability of HepG2 cells [31,32]. A dichloromethane
residue was almost two-fold more cytotoxic against the leukemic cells P-388 compared to the lung
carcinoma NSCLC-N6; however, the ethanol extract appeared to be almost inactive against these
cell lines. The difference in their activity could be attributed to the presence of ursolic acid in the
dichloromethane residue, which was shown to be more cytotoxic than the residue against the cancer
cell lines [33]. Finally, the herbal infusion of the aerial parts of the plant was the most cytotoxic against
HT-29 and PC-3 cells compared to infusions from other Greek plants [34].
Antioxidants 2019, 8, 290 13 of 18
In the same study, Rosmarinus officinalis (rosemary), Thymus vulgaris (thyme), Origanum majorana
(marjoram), Salvia officinalis (sage), and Hypericum perforatum (St John’s Wort) were also studied.
The infusions of marjoram and St John’s wort were the least cytotoxic against HT-29 cells, while PC-3
were the least sensitive against thyme. St John’s Wort in HT29 and thyme in PC3 cells caused reduction
of the levels of the p65 NF-kB subunit and all infusions decreased the levels of the pro-inflammatory
interleukin 8, in an order depending on the cell line. The authors could not make a correlation between
the antiproliferative profile of the extracts and their composition.
A similar study was conducted a year before, in 2013, where the antiproliferative activity of herbal
infusions from leaves and flowers of the plants Origanum vulgare, Origanum microphyllum, Satureja
thymbra (pink savory), Sideritis syriaca (mountain tea), Mentha pulegium (pennyroyal), and Matricaria
chamomilla (chamomile) was tested [39]. The authors showed that pink savory was the most cytotoxic
against HT-29 and PC-3 cells, while chamomile infusion and chamomile together with mountain tea
were the least effective against HT-29 and PC-3 cells, respectively. However, the infusion of chamomile
was the only one that caused statistically significant reduction of the p65 NF-kB subunit in HT-29
cells. In addition, all infusions were able to decrease the levels of interleukin-8 in the following order:
HT-29: mountain tea > pennyroyal > chamomile > Origanum microphyllum > pink savory> Origanum
vulgare, PC-3: Origanum microphyllum > pennyroyal > pink savory > Origanum vulgare > chamomile >
mountain tea.
St. John’s Wort is mainly known for its use against depression and anxiety; however, there is
emerging evidence for its potential against cancer, too [53]. The aqueous and methanolic solution
(AS and MS) as well as the methanolic and petroleum ether extracts (ME and PEE) of St John’s
Wort from Epirus were tested against the urinary bladder carcinoma T24 and the rat urinary bladder
carcinoma NBT-II. The MS was more potent than the AS against T24 cells and the same applied for
the PEE compared to the ME. The PEE was also more cytotoxic than the ME against the NBT-II cell
line, which is attributed to yet unidentifiable components of the herb. PEE was also shown to induce
apoptosis in both cell lines using the TUNEL assay [36]. A methanolic extract of the plant together
with methanolic extracts from four other species of the genus Hypericum (H. empetrifolium, perfoliatum,
rumeliacum, triquetrifolium) showed diverse antioxidant activity and cytotoxicity against Caco2 and
HepG2 cells, with the extracts of H. empetrifolium Wild from three different locations being the most
cytotoxic; however, the concentrations used were very high [37]. Methanolic extracts from aerial parts
of different St John’s wort’s chemotypes from different locations (cultivated and wild) were tested
against Caco2 cells [35]. The highest activity was presented by one of the cultivated chemotypes,
followed by one of the wild populations, while the other extracts did not affect cell viability at all.
They also included a commercial sample in their analysis, but it was not of Greek origin. The authors
found positive correlation between the antiproliferative activity and the content in rutin and hyperforin,
two main components of Hypericum species. Differences in their content were attributed to different
environmental conditions at the growing sites of the plants.
The methanolic extracts of pennyroyal and rosemary and other 16 plants mainly from Attiki
region and Lesvos island (Clinopodium vulgare L., Lavandula stoechas L., Micromeria juliana L. Bentham
ex Reinchenb., Nepeta argolica Bory et Chaub. subsp. argolica, Phlomis pungens Wild., Satureja graeca L.,
Scutellaria rupestris Boiss. & Heldr., Sideritis sipylea Boiss., Stachys spruneri Boiss., Teucrium divaricatum
Heldr. subsp. divaricatum, Teucrium polium L., Thymus atticus C˘elak., Thymus longicaulis C. Presl, Thymus
parnassicus Halacsy, Thymus samius Ronniger & Rech., Thymus teucrioides Boiss. & Spruner) have been
investigated against three human cancer cells lines (MCF-7, Caco2, HepG2) and normal mouse adipose
areolar cells [40]. Rosemary was the most potent against MCF-7 cells, while Thymus parnassicus Halácsy
against Caco2 and HepG2; however, rosemary extract was also the most cytotoxic towards the normal
mouse cell line used. In the same study, the extracts were also tested for their toxicity against brine
shrimps and pennyroyal was found to be the most cytotoxic (LC50 = 347.3 µg/mL).
The genus Teucrium can be found worldwide but mostly in the Mediterranean region. Menichini
and her colleagues in 2009 studied the antiproliferative potential of four Teucrium species from
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Greece [38]. More specifically, the essential oil from the aerial parts of T. brevifolium, T. flavum,
T. montbretii ssp. Heliotropiifolium, and T. polium ssp. capitatum were isolated and studied against lung
carcinoma COR-L23, colorectal adenocarcinoma Caco2, and amelanotic melanoma C32. They observed
that T. brevifolium oil was the most potent against COR-L23 cells, while Teucrium polium ssp. capitatum was
the most potent against Caco2 and C32 cells. The authors attributed the diverse activity to the different
classes of compounds present in the oils (different classes of sesquiterpenes). All oils also exhibited
anti-inflammatory activity, being able to inhibit LPS-induced NO production, with T. brevifolium
possessing the highest capacity.
Crocus sativus L. is an aromatic flowering plant, which produces saffron spice, the most expensive
spice in the world, known as “red gold” [54]. The herb has been widely used by ancient Indian, Arabic,
and Chinese civilizations as medicine, but is also studied nowadays for its therapeutic potential against
several pathological conditions including depression, diabetes, and cancer [55]. In a recent study,
Giakoumettis and his colleagues investigated the antiproliferative effect of an ethanolic saffron extract
against rat glioma cells C6 alone or in combination with the chemotherapeutic drug temozolomide
(TMZ). They showed that the saffron extract is cytotoxic against the cell line after 48 h of treatment and
in some combinations, it enhances the cytotoxicity of the drug, too. In addition, they demonstrated that
the extract does not induce apoptosis, but calpain-dependent death, possibly through the activation of
autophagy and also impairs the colony formation potential of the cells [22].
The genus Marrubium consists of approximately 50 species native to temperate regions of the
world. The methanolic extract of the species Marrubium thessalum Boiss. & Heldr from Olympus
Mountain was tested against four commonly diagnosed cancer types: Breast adenocarcinoma MCF-7,
cervix adenocarcinoma HeLa, colon carcinoma HCT116, and melanoma FM3. It was found to be
more cytotoxic against HeLa cells, while exhibiting similar but lower cytotoxic potency in the other
cell lines. In addition, the methanolic extract was also tested against human peripheral blood
mononuclear cells (PBMCs) where it was found to be the most cytotoxic compared to some of
its phenolic compounds (acteoside, leucosceptoside A, forsythoside B, alyssonoside, isoacteoside
decaffeoyl-acteoside) indicating that it does not selectively kill cancer cells, in contrast to its components,
which are promising agents for further studies [27].
Another member of the Lamiaceae family, the genus Ocimum consists of 30 species that are
cultivated all around the world. Ocimum basilicum, also known as sweet basil, is one of the most
popular food spices in the world and has been studied for its antimicrobial and pharmaceutical
properties [56]. In 2014, the essential oil and ethanolic extract of sweet basil from Greece were studied
for their action against the cervix adenocarcinoma HeLa, melanoma FemX, chronic myelogenous
leukemia K562, and ovary adenocarcinoma SKOV3 cells lines [26]. The researchers observed that
both extracts showed similar activity against SKOV3 and K562 cells, while the oil was two-fold more
cytotoxic against HeLa and FemX cells. The oil exhibited the highest and similar activity against HeLa
and FemX cells, followed by K562 and SKOV3. The ethanolic extract, on the other hand, was more
cytotoxic against K562 cells, followed by HeLa, FemX, and SKOV3. Their activities were considered
“mild but notable” compared to their main components. In general, with the exception of few cases,
the components exhibited more significant activity and were considered to be responsible for the
activity of the extracts. Those components were caffeic and rosmarinic acids for the ethanolic extract
and eugenol and isoeugenol for sweet basil oil. Furthermore, the chemical composition of basil oil
together with the essential oils isolated from the plants Fortunella margarita (kumquat), Mentha spicata
(spearmint), and Pimpinella anisum (anise) was analyzed and their biological properties (antimicrobial,
antioxidant, antiproliferative) were determined [25]. All of these plants are widely used for culinary
purposes in Greece and as flavorings in beverages, gums, ice creams, etc. None of the essential oils
exhibited significant antioxidant activity in vitro, whereas their cytotoxicity depended on the cell line
used (HepG2, MCF-7, Caco2, THP-1). In general, sweet basil oil was the most cytotoxic against most of
the cancer preclinical models used in the study, while kumquat and anise oils were the most efficient
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against THP-1 cells. Spearmint oil demonstrated an intermediate effect and it was the least cytotoxic
against THP-1 cells.
4. Conclusions
Cancer incidence and mortality are constantly increasing, and novel strategies are required
for its prevention and treatment. Products of natural origin have been used for their medicinal
properties since ancient times and in the last years interest in these properties has increased. Currently,
numerous studies exist investigating their pharmaceutical potential, including their chemopreventive
and chemotherapeutic effect. Although the number of aromatic plant extracts of Greek origin that have
been studied for their antiproliferative activity is limited, existing data against several cancer types are
promising and encourage further exploitation of the country’s unique flora diversity. Undoubtedly,
further exploration of the molecular mechanisms of action of the extracts and their components is
required not only in vitro but in vivo as well, to verify and establish their activity for their future use
in the battle against cancer.
Author Contributions: Conceptualization, E.F. and A.P.; Investigation, Collecting sources of information,
E.F, Writing—Original Draft Preparation E.F.; Writing—Review & Editing, A.P.; Supervision, A.P.; Funding
acquisition, A.P.
Funding: We acknowledge support of this work by the project «OPENSCREEN-GR: An Open-Access Research
Infrastructure of Target-Based Screening Technologies and Chemical Biology for Human and Animal Health,
Agriculture and Environment» (MIS 5002691) which is implemented under the Action “Reinforcement of
the Research and Innovation Infrastructure”, funded by the Operational Programme “Competitiveness,
Entrepreneurship and Innovation” (NSRF 2014-2020) and co-financed by Greece and the European Union
(European Regional Development Fund).
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Svoboda, K.; Greenaway, R. Investigation of volatile oil glands of Satureja hortensis L. (summer savory) and
phytochemical comparison of different varieties. Int. J. Aromather. 2003, 13, 196–202. [CrossRef]
2. Commission of the European Communities. Council Directive 92/43/EEC of 21 May 1992 on the conservation
of natural habitats and of wild fauna and flora. Off. J. Eur. Communities 1992, 206, 7–50.
3. Dimopoulos, P.; Raus, T.; Bergmeier, E.; Constantinidis, T.; Iatrou, G.; Kokkini, S.; Strid, A.; Tzanoudakis, D.
Vascular plants of Greece: An annotated checklist. Supplement. Willdenowia 2016, 46, 301–347. [CrossRef]
4. Kantsa, A.; Sotiropoulou, S.; Vaitis, M.; Petanidou, T. Plant Volatilome in Greece: A Review on the Properties,
Prospects, and Chemogeography. Chem. Biodivers. 2015, 12, 1466–1480. [CrossRef] [PubMed]
5. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018:
GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer
J. Clin. 2018, 68, 394–424. [CrossRef] [PubMed]
6. OECD/European Observatory on Health Systems and Policies. Greece: Country Health Profile 2017, State of
Health in the EU; Paris/European Observatory on Health Systems and Policies: Brussels, Belgium, 2017.
7. Ferlay, J.; Colombet, M.; Soerjomataram, I.; Dyba, T.; Randi, G.; Bettio, M.; Gavin, A.; Visser, O.; Bray, F.
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.
Eur. J. Cancer 2018, 103, 356–387. [CrossRef]
8. Bamia, C. Dietary patterns in association to cancer incidence and survival: Concept, current evidence, and
suggestions for future research. Eur. J. Clin. Nutr. 2018, 72, 818–825. [CrossRef]
9. Stewart, B.; Wild, C. (Eds.) World Cancer Report 2014; International Agency for Research on Cancer: Lyon,
France, 2014.
10. World Cancer Research Fund and American Institute for Cancer Research. Whole Grains, Vegetables and
Fruit and the Risk of Cancer. Available online: https://www.wcrf.org/sites/default/files/Wholegrains-veg-
and-fruit.pdf (accessed on 6 August 2019).
Antioxidants 2019, 8, 290 16 of 18
11. Karageorgou, D.; Magriplis, E.; Mitsopoulou, A.V.; Dimakopoulos, I.; Bakogianni, I.; Micha, R.; Michas, G.;
Chourdakis, M.; Ntouroupi, T.; Tsaniklidou, S.M.; et al. Dietary patterns and lifestyle characteristics in adults:
Results from the Hellenic National Nutrition and Health Survey (HNNHS). Public Health 2019, 171, 76–88.
[CrossRef]
12. Trichopoulou, A.; Costacou, T.; Bamia, C.; Trichopoulos, D. Adherence to a Mediterranean diet and survival
in a Greek population. N. Engl. J. Med. 2003, 348, 2599–2608. [CrossRef]
13. Buriani, A.; Fortinguerra, S.; Sorrenti, V.; Dall’Acqua, S.; Innocenti, G.; Montopoli, M.; Gabbia, D.; Carrara, M.
Human Adenocarcinoma Cell Line Sensitivity to Essential Oil Phytocomplexes from Pistacia Species:
A Multivariate Approach. Molecules 2017, 22, 1336. [CrossRef]
14. Loutrari, H.; Magkouta, S.; Pyriochou, A.; Koika, V.; Kolisis, F.N.; Papapetropoulos, A.; Roussos, C. Mastic oil
from Pistacia lentiscus var. chia inhibits growth and survival of human K562 leukemia cells and attenuates
angiogenesis. Nutr. Cancer 2006, 55, 86–93. [CrossRef] [PubMed]
15. Loutrari, H.; Magkouta, S.; Papapetropoulos, A.; Roussos, C. Mastic oil inhibits the metastatic phenotype of
mouse lung adenocarcinoma cells. Cancers 2011, 3, 789–801. [CrossRef] [PubMed]
16. Magkouta, S.; Stathopoulos, G.T.; Psallidas, I.; Papapetropoulos, A.; Kolisis, F.N.; Roussos, C.; Loutrari, H.
Protective effects of mastic oil from Pistacia lentiscus variation chia against experimental growth of lewis
lung carcinoma. Nutr. Cancer 2009, 61, 640–648. [CrossRef] [PubMed]
17. Moulos, P.; Papadodima, O.; Chatziioannou, A.; Loutrari, H.; Roussos, C.; Kolisis, F.N. A transcriptomic
computational analysis of mastic oil-treated Lewis lung carcinomas reveals molecular mechanisms targeting
tumor cell growth and survival. BMC Med. Genomics 2009, 2, 68. [CrossRef] [PubMed]
18. Spyridopoulou, K.; Tiptiri-Kourpeti, A.; Lampri, E.; Fitsiou, E.; Vasileiadis, S.; Vamvakias, M.; Bardouki, H.;
Goussia, A.; Malamou-Mitsi, V.; Panayiotidis, M.I.; et al. Dietary mastic oil extracted from Pistacia lentiscus
var. chia suppresses tumor growth in experimental colon cancer models. Sci. Rep. 2017, 7, 3782. [CrossRef]
19. Balan, K.V.; Prince, J.; Han, Z.; Dimas, K.; Cladaras, M.; Wyche, J.H.; Sitaras, N.M.; Pantazis, P. Antiproliferative
activity and induction of apoptosis in human colon cancer cells treated in vitro with constituents of a product
derived from Pistacia lentiscus L. var. chia. Phytomedicine 2007, 14, 263–272. [CrossRef] [PubMed]
20. Balan, K.V.; Demetzos, C.; Prince, J.; Dimas, K.; Cladaras, M.; Han, Z.; Wyche, J.H.; Pantazis, P. Induction of
apoptosis in human colon cancer HCT116 cells treated with an extract of the plant product, Chios mastic
gum. In Vivo 2005, 19, 93–102.
21. Dimas, K.; Hatziantoniou, S.; Wyche, J.H.; Pantazis, P. A mastic gum extract induces suppression of growth
of human colorectal tumor xenografts in immunodeficient mice. In Vivo 2009, 23, 63–68.
22. Giakoumettis, D.; Pourzitaki, C.; Vavilis, T.; Tsingotjidou, A.; Kyriakoudi, A.; Tsimidou, M.; Boziki, M.;
Sioga, A.; Foroglou, N.; Kritis, A. Calpain-Dependent Death in C6 Rat Glioma Cells, Exhibiting a Synergistic
Effect with Temozolomide. Nutr. Cancer 2019, 71, 491–507. [CrossRef]
23. Fitsiou, E.; Mitropoulou, G.; Spyridopoulou, K.; Vamvakias, M.; Bardouki, H.; Galanis, A.; Chlichlia, K.;
Kourkoutas, Y.; Panayiotidis, M.; Pappa, A. Chemical Composition and Evaluation of the Biological Properties
of the Essential Oil of the Dietary Phytochemical Lippia citriodora. Molecules 2018, 23, 123. [CrossRef]
24. Mitropoulou, G.; Fitsiou, E.; Spyridopoulou, K.; Tiptiri-Kourpeti, A.; Bardouki, H.; Vamvakias, M.; Panas, P.;
Chlichlia, K.; Pappa, A.; Kourkoutas, Y. Citrus medica essential oil exhibits significant antimicrobial and
antiproliferative activity. LWT Food Sci. Technol. 2017. [CrossRef]
25. Fitsiou, E.; Mitropoulou, G.; Spyridopoulou, K.; Tiptiri-Kourpeti, A.; Vamvakias, M.; Bardouki, H.;
Panayiotidis, M.; Galanis, A.; Kourkoutas, Y.; Chlichlia, K.; et al. Phytochemical Profile and Evaluation of the
Biological Activities of Essential Oils Derived from the Greek Aromatic Plant Species Ocimum basilicum,
Mentha spicata, Pimpinella anisum and Fortunella margarita. Molecules 2016, 21, 1069. [CrossRef] [PubMed]
26. Zarlaha, A.; Kourkoumelis, N.; Stanojkovic, T.; Kovala-Demertzi, D. Cytotoxic Activity Of Essential oil and
Extracts of Ocimum Basilicum Against Human Carcinoma Cells. Molecular Docking Study of Isoeugenol as a
Potent Cox and Lox Inhibitor. Dig. J. Nanomater. Biostructures (DJNB) 2014, 9, 907–917.
27. Argyropoulou, A.; Samara, P.; Tsitsilonis, O.; Skaltsa, H. Polar constituents of Marrubium thessalum Boiss. &
Heldr. (Lamiaceae) and their cytotoxic/cytostatic activity. Phytother. Res. 2012, 26, 1800–1806. [CrossRef]
[PubMed]
28. Fitsiou, E.; Anestopoulos, I.; Chlichlia, K.; Galanis, A.; Kourkoutas, I.; Panayiotidis, M.I.; Pappa, A.
Antioxidant and Antiproliferative Properties of the Essential Oils of Satureja thymbra and Satureja parnassica
and their Major Constituents. Anticancer Res. 2016, 36, 5757–5763. [CrossRef] [PubMed]
Antioxidants 2019, 8, 290 17 of 18
29. Sivropoulou, A.; Papanikolaou, E.; Nikolaou, C.; Kokkini, S.; Lanaras, T.; Arsenakis, M. Antimicrobial and
cytotoxic activities of Origanum essential oils. J. Agric. Food Chem. 1996, 44, 1202–1205. [CrossRef]
30. Spyridopoulou, K.; Fitsiou, E.; Bouloukosta, E.; Tiptiri-Kourpeti, A.; Vamvakias, M.; Oreopoulou, A.;
Papavassilopoulou, E.; Pappa, A.; Chlichlia, K. Extraction, Chemical Composition, and Anticancer Potential
of Origanum onites L. Essential Oil. Molecules 2019, 24, 2612. [CrossRef] [PubMed]
31. Mitropoulou, G.; Fitsiou, E.; Stavropoulou, E.; Papavassilopoulou, E.; Vamvakias, M.; Pappa, A.;
Oreopoulou, A.; Kourkoutas, Y. Composition, antimicrobial, antioxidant, and antiproliferative activity
of Origanum dictamnus (dittany) essential oil. Microb. Ecol. Health Dis. 2015, 26, 26543. [PubMed]
32. Marrelli, M.; Conforti, F.; Formisano, C.; Rigano, D.; Arnold, N.A.; Menichini, F.; Senatore, F. Composition,
antibacterial, antioxidant and antiproliferative activities of essential oils from three Origanum species
growing wild in Lebanon and Greece. Nat. Prod. Res. 2016, 30, 735–739. [CrossRef]
33. Chinou, I.; Liolios, C.; Moreau, D.; Roussakis, C. Cytotoxic activity of Origanum dictamnus. Fitoterapia 2007,
78, 342–344. [CrossRef]
34. Kaliora, A.C.; Kogiannou, D.A.; Kefalas, P.; Papassideri, I.S.; Kalogeropoulos, N. Phenolic profiles and
antioxidant and anticarcinogenic activities of Greek herbal infusions; balancing delight and chemoprevention?
Food Chem. 2014, 142, 233–241. [CrossRef] [PubMed]
35. Sarrou, E.; Giassafaki, L.P.; Masuero, D.; Perenzoni, D.; Vizirianakis, I.S.; Irakli, M.; Chatzopoulou, P.;
Martens, S. Metabolomics assisted fingerprint of Hypericum perforatum chemotypes and assessment of
their cytotoxic activity. Food Chem. Toxicol. 2018, 114, 325–333. [CrossRef] [PubMed]
36. Skalkos, D.; Stavropoulos, N.E.; Tsimaris, I.; Gioti, E.; Stalikas, C.D.; Nseyo, U.O.; Ioachim, E.; Agnantis, N.J.
The lipophilic extract of Hypericum perforatum exerts significant cytotoxic activity against T24 and NBT-II
urinary bladder tumor cells. Planta Med. 2005, 71, 1030–1035. [CrossRef] [PubMed]
37. Couladis, M.; Badisa, R.B.; Baziou, P.; Chaudhuri, S.K.; Pilarinou, E.; Verykokidou, E.; Harvala, C. Antioxidant
and cytotoxic activities of Hypericum sp. on brine shrimps and human cancer cell lines. Phytother. Res. 2002,
16, 719–722. [CrossRef] [PubMed]
38. Menichini, F.; Conforti, F.; Rigano, D.; Formisano, C.; Piozzi, F.; Senatore, F. Phytochemical composition,
anti-inflammatory and antitumour activities of four Teucrium essential oils from Greece. Food Chem. 2009,
115, 679–686. [CrossRef]
39. Kogiannou, D.A.; Kalogeropoulos, N.; Kefalas, P.; Polissiou, M.G.; Kaliora, A.C. Herbal infusions; their
phenolic profile, antioxidant and anti-inflammatory effects in HT29 and PC3 cells. Food Chem. Toxicol. 2013,
61, 152–159. [CrossRef] [PubMed]
40. Badisa, R.B.; Tzakou, O.; Couladis, M.; Pilarinou, E. Cytotoxic activities of some Greek Labiatae herbs.
Phytother. Res. 2003, 17, 472–476. [CrossRef] [PubMed]
41. Arias, B.A.; Ramón-Laca, L. Pharmacological properties of citrus and their ancient and medieval uses in the
Mediterranean region. J. Ethnopharmacol. 2005, 97, 89–95. [CrossRef]
42. Quirantes-Piné, R.; Herranz-López, M.; Funes, L.; Borrás-Linares, I.; Micol, V.; Segura-Carretero, A.;
Fernández-Gutiérrez, A. Phenylpropanoids and their metabolites are the major compounds responsible for
blood-cell protection against oxidative stress after administration of Lippia citriodora in rats. Phytomedicine
2013, 20, 1112–1118. [CrossRef]
43. Pascual, M.E.; Slowing, K.; Carretero, E.; Sánchez Mata, D.; Villar, A. Lippia: Traditional uses, chemistry and
pharmacology: A review. J. Ethnopharmacol. 2001, 76, 201–214. [CrossRef]
44. Chorianopoulos, N.; Kalpoutzakis, E.; Aligiannis, N.; Mitaku, S.; Nychas, G.-J.; Haroutounian, S.A. Essential
oils of Satureja, Origanum, and Thymus species: Chemical composition and antibacterial activities against
foodborne pathogens. J. Agric. Food Chem. 2004, 52, 8261–8267. [CrossRef] [PubMed]
45. Chorianopoulos, N.G.; Lambert, R.J.; Skandamis, P.N.; Evergetis, E.T.; Haroutounian, S.A.; Nychas, G.J. A
newly developed assay to study the minimum inhibitory concentration of Satureja spinosa essential oil. J.
Appl. Microbiol. 2006, 100, 778–786. [CrossRef] [PubMed]
46. Ayvaz, A.; Sagdic, O.; Karaborklu, S.; Ozturk, I. Insecticidal activity of the essential oils from different plants
against three stored-product insects. J. Insect Sci. 2010, 10, 21. [CrossRef] [PubMed]
47. Giweli, A.; Džamic´, A.M.; Sokovic´, M.; Ristic´, M.S.; Marin, P.D. Antimicrobial and antioxidant activities of
essential oils of Satureja thymbra growing wild in Libya. Molecules 2012, 17, 4836–4850. [CrossRef] [PubMed]
Antioxidants 2019, 8, 290 18 of 18
48. Loizzo, M.R.; Tundis, R.; Menichini, F.; Saab, A.M.; Statti, G.A.; Menichini, F. Cytotoxic activity of essential
oils from Labiatae and Lauraceae families against in vitro human tumor models. Anticancer Res. 2007, 27,
3293–3299. [PubMed]
49. Michaelakis, A.; Theotokatos, S.A.; Koliopoulos, G.; Chorianopoulos, N.G. Essential oils of satureja species:
Insecticidal effect on Culex pipiens larvae (Diptera: Culicidae). Molecules 2007, 12, 2567–2578. [CrossRef]
[PubMed]
50. Sharifi-Rad, M.; Varoni, E.M.; Iriti, M.; Martorell, M.; Setzer, W.N.; Del Mar Contreras, M.; Salehi, B.;
Soltani-Nejad, A.; Rajabi, S.; Tajbakhsh, M.; et al. Carvacrol and human health: A comprehensive review.
Phytother. Res. 2018, 32, 1675–1687. [CrossRef] [PubMed]
51. Vokou, D.; Katradi, K.; Kokkini, S. Ethnobotanical survey of Zagori (Epirus, Greece), a renowned centre of
folk medicine in the past. J. Ethnopharmacol. 1993, 39, 187–196. [CrossRef]
52. Tepe, B.; Cakir, A.; Sihoglu Tepe, A. Medicinal Uses, Phytochemistry, and Pharmacology of Origanum onites
(L.): A Review. Chem. Biodivers. 2016, 13, 504–520. [CrossRef] [PubMed]
53. Klemow, K.M.; Bartlow, A.; Crawford, J.; Kocher, N.; Shah, J.; Ritsick, M. Medical Attributes of St. John’s
Wort (Hypericum perforatum). In Herbal Medicine: Biomolecular and Clinical Aspects, 2nd ed.; Benzie, I.F.F.,
Wachtel-Galor, S., Eds.; CRC Press: Boca Raton, FL, USA, 2011.
54. José Bagur, M.; Alonso Salinas, G.L.; Jiménez-Monreal, A.M.; Chaouqi, S.; Llorens, S.; Martínez-Tomé, M.;
Alonso, G.L. Saffron: An Old Medicinal Plant and a Potential Novel Functional Food. Molecules 2017, 23, 30.
[CrossRef] [PubMed]
55. Leone, S.; Recinella, L.; Chiavaroli, A.; Orlando, G.; Ferrante, C.; Leporini, L.; Brunetti, L.; Menghini, L.
Phytotherapic use of the Crocus sativus L. (Saffron) and its potential applications: A brief overview.
Phytother. Res. 2018. [CrossRef] [PubMed]
56. Bower, A.; Marquez, S.; de Mejia, E.G. The Health Benefits of Selected Culinary Herbs and Spices Found in
the Traditional Mediterranean Diet. Crit. Rev. Food Sci. Nutr. 2016, 56, 2728–2746. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
